MetLife Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Hold |
|
|||||
|
2025
Q1 | $796K | Buy |
|
|||||
|
2024
Q4 | $750K | Buy |
|
|||||
|
2024
Q3 | $768K | Hold |
|
|||||
|
2024
Q2 | $586K | Buy |
|
|||||
|
2024
Q1 | $344K | Sell |
|
|||||
|
2023
Q4 | $418K | Hold |
|
|||||
|
2023
Q3 | $290K | Hold |
|
|||||
|
2023
Q2 | $213K | Buy |
|
|||||
|
2023
Q1 | $38.7K | Sell |
|
|||||
|
2022
Q4 | $92.6K | Sell |
|
|||||
|
2022
Q3 | $113K | Buy |
|
|||||
|
2022
Q2 | $93.1K | Sell |
|
|||||
|
2022
Q1 | $243K | Buy |
|
|||||
|
2021
Q4 | $104K | Sell |
|
|||||
|
2021
Q3 | $216K | Hold |
|
|||||
|
2021
Q2 | $207K | Hold |
|
|||||
|
2021
Q1 | $272K | Buy |
|
|||||
|
2020
Q4 | $96K | Sell |
|
|||||
|
2020
Q3 | $135K | Sell |
|
|||||
|
2020
Q2 | $263K | Hold |
|
|||||
|
2020
Q1 | $192K | Hold |
|
|||||
|
2019
Q4 | $266K | Buy |
|
|||||
|
2019
Q3 | $118K | Hold |
|
|||||
|
2019
Q2 | $291K | Hold |
|
|||||
|
2019
Q1 | $574K | Hold |
|
|||||
|
2018
Q4 | $548K | Hold |
|
|||||
|
2018
Q3 | $900K | Buy |
|